- Home
- SXTC vs CCCC Comparison
SXTC vs CCCC Comparison
Compare SXTC & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- CCCC
- Stock Information
- Founded
- SXTC 2005
- CCCC 2015
- Country
- SXTC China
- CCCC United States
- Employees
- SXTC N/A
- CCCC N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- SXTC Health Care
- CCCC Health Care
- Exchange
- SXTC Nasdaq
- CCCC Nasdaq
- Market Cap
- SXTC 164.8M
- CCCC 175.1M
- IPO Year
- SXTC 2019
- CCCC 2020
- Fundamental
- Price
- SXTC $1.90
- CCCC $3.32
- Analyst Decision
- SXTC
- CCCC Strong Buy
- Analyst Count
- SXTC 0
- CCCC 4
- Target Price
- SXTC N/A
- CCCC $8.50
- AVG Volume (30 Days)
- SXTC 860.1K
- CCCC 1.3M
- Earning Date
- SXTC 01-01-0001
- CCCC 10-30-2025
- Dividend Yield
- SXTC N/A
- CCCC N/A
- EPS Growth
- SXTC N/A
- CCCC N/A
- EPS
- SXTC N/A
- CCCC N/A
- Revenue
- SXTC $1,740,907.00
- CCCC $34,240,000.00
- Revenue This Year
- SXTC N/A
- CCCC N/A
- Revenue Next Year
- SXTC N/A
- CCCC N/A
- P/E Ratio
- SXTC N/A
- CCCC N/A
- Revenue Growth
- SXTC N/A
- CCCC 16.55
- 52 Week Low
- SXTC $0.95
- CCCC $1.09
- 52 Week High
- SXTC $7.84
- CCCC $7.14
- Technical
- Relative Strength Index (RSI)
- SXTC 60.38
- CCCC 67.30
- Support Level
- SXTC $1.33
- CCCC $3.21
- Resistance Level
- SXTC $1.97
- CCCC $3.65
- Average True Range (ATR)
- SXTC 0.21
- CCCC 0.25
- MACD
- SXTC 0.05
- CCCC 0.07
- Stochastic Oscillator
- SXTC 81.91
- CCCC 75.00
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.